[
  {
    "title": "金城医药(300233.SZ)：利他唑酮干混悬剂(LT-01)项目完成Ⅰ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/16175937144205.shtml",
    "datetime": "2022-11-16 17:59:53",
    "code": "300233"
  },
  {
    "title": "金城医药2022年前三季度净利2.58亿同比增长114.72% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2022/10/25175037082247.shtml",
    "datetime": "2022-10-25 17:50:56",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：第三季度净利增44.23%至3942.35万元",
    "href": "http://stock.jrj.com.cn/2022/10/25160137081661.shtml",
    "datetime": "2022-10-25 16:01:53",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司金城金素通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2022/10/18180537064635.shtml",
    "datetime": "2022-10-18 18:05:08",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司注射用头孢呋辛钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/29175537031589.shtml",
    "datetime": "2022-09-29 17:55:36",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司注射用头孢曲松钠获批增加规格补充批件",
    "href": "http://stock.jrj.com.cn/2022/08/31080736955982.shtml",
    "datetime": "2022-08-31 08:07:12",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)上半年净利2.19亿元，同比增长135.44%",
    "href": "http://stock.jrj.com.cn/2022/08/24163936930663.shtml",
    "datetime": "2022-08-24 16:39:29",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司注射用头孢唑林钠获批增加规格补充批件",
    "href": "http://stock.jrj.com.cn/2022/07/27173336847426.shtml",
    "datetime": "2022-07-27 17:33:06",
    "code": "300233"
  },
  {
    "title": "金城医药：控股子公司参与全国药品集采拟中选 将进一步扩大相关产品销售",
    "href": "http://stock.jrj.com.cn/2022/07/13142236807065.shtml",
    "datetime": "2022-07-13 14:22:42",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：克林霉素磷酸酯注射液拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13122436806822.shtml",
    "datetime": "2022-07-13 12:24:23",
    "code": "300233"
  },
  {
    "title": "金城医药：上半年净利预增超115%，经营能力持续向好",
    "href": "http://stock.jrj.com.cn/2022/07/08145836818327.shtml",
    "datetime": "2022-07-08 14:58:40",
    "code": "300233"
  },
  {
    "title": "金城医药2022年上半年预计净利2亿-2.5亿同比增长115%-169% 销售收入增长",
    "href": "http://stock.jrj.com.cn/2022/07/07205236792229.shtml",
    "datetime": "2022-07-07 20:52:52",
    "code": "300233"
  },
  {
    "title": "新增CMO业务 金城医药(300233.SZ)上半年净利预增115.03%-168.79%",
    "href": "http://stock.jrj.com.cn/2022/07/07171736791299.shtml",
    "datetime": "2022-07-07 17:17:13",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司泊沙康唑原料药生产线通过GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2022/07/05173536784005.shtml",
    "datetime": "2022-07-05 17:35:18",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金城医化获得烟草专卖生产企业许可证(电子烟用烟碱生产企业)",
    "href": "http://stock.jrj.com.cn/2022/06/22165036749958.shtml",
    "datetime": "2022-06-22 16:50:33",
    "code": "300233"
  },
  {
    "title": "金城医药：全资子公司收到烟草专卖生产企业许可证",
    "href": "http://stock.jrj.com.cn/2022/06/22164436749833.shtml",
    "datetime": "2022-06-22 16:44:23",
    "code": "300233"
  },
  {
    "title": "拿下国内首张电子烟专卖许可证，金城医药欲借尼古丁“破局”业绩瓶颈？",
    "href": "http://stock.jrj.com.cn/2022/06/17191836739044.shtml",
    "datetime": "2022-06-17 19:18:16",
    "code": "300233"
  },
  {
    "title": "金城医药子公司获电子烟专卖许可证，多家公司看好前景早已布局",
    "href": "http://stock.jrj.com.cn/2022/06/14094436726608.shtml",
    "datetime": "2022-06-14 09:44:14",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药(300233.SZ)高开3.96% 全资子公司获电子烟专卖许可决定书",
    "href": "http://stock.jrj.com.cn/2022/06/14092836726448.shtml",
    "datetime": "2022-06-14 09:28:09",
    "code": "300233"
  },
  {
    "title": "金城医药获电子烟专卖许可决定书",
    "href": "http://stock.jrj.com.cn/2022/06/14090136726370.shtml",
    "datetime": "2022-06-14 09:01:10",
    "code": "300233"
  },
  {
    "title": "【晚间公告全知道】川能动力拟合资投建3万吨/年锂盐项目、金城医药获电子烟专卖许可决定书",
    "href": "http://stock.jrj.com.cn/2022/06/13215136725737.shtml",
    "datetime": "2022-06-13 21:51:25",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金城医化收到烟草专卖许可证准予许可决定书",
    "href": "http://stock.jrj.com.cn/2022/06/13183436725046.shtml",
    "datetime": "2022-06-13 18:34:36",
    "code": "300233"
  },
  {
    "title": "【互动】金城医药：俄乌战争对公司产生的影响总体可控",
    "href": "http://stock.jrj.com.cn/2022/06/07152536708969.shtml",
    "datetime": "2022-06-07 15:25:51",
    "code": "300233"
  },
  {
    "title": "金城医药：拟1000万元增资孚斯泰，后者拟开发核酸快检系列产品",
    "href": "http://stock.jrj.com.cn/2022/05/27121736684065.shtml",
    "datetime": "2022-05-27 12:17:57",
    "code": "300233"
  },
  {
    "title": "金城医药：拟1000万元增资孚斯泰 后者拟开发核酸快检系列产品",
    "href": "http://stock.jrj.com.cn/2022/05/26210136682558.shtml",
    "datetime": "2022-05-26 21:01:05",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：拟以1000万元增资杭州孚斯泰生物",
    "href": "http://stock.jrj.com.cn/2022/05/26205536682547.shtml",
    "datetime": "2022-05-26 20:55:05",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金方恒健投资的惠和生物三特异性抗CC312IND申请获美国FDA默示许可",
    "href": "http://stock.jrj.com.cn/2022/05/16213436652985.shtml",
    "datetime": "2022-05-16 21:34:33",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金城金素的克林霉素磷酸酯注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/05/16210036652886.shtml",
    "datetime": "2022-05-16 21:00:34",
    "code": "300233"
  },
  {
    "title": "金城医药2022年第一季度净利1.12亿 同比增加121% 主营产品销售收入增加",
    "href": "http://stock.jrj.com.cn/2022/05/04193236558832.shtml",
    "datetime": "2022-05-04 19:32:40",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司取得药品批件",
    "href": "http://stock.jrj.com.cn/2022/04/06213036264777.shtml",
    "datetime": "2022-04-06 21:30:10",
    "code": "300233"
  },
  {
    "title": "金城医药股东北京锦圣减持767.73万股 套现2.55亿 2021年公司净利1.08亿",
    "href": "http://stock.jrj.com.cn/2022/04/01223136249057.shtml",
    "datetime": "2022-04-01 22:31:51",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：北京锦圣完成减持2%股份",
    "href": "http://stock.jrj.com.cn/2022/04/01181936248093.shtml",
    "datetime": "2022-04-01 18:19:33",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药(300233.SZ)放量升超9% 年度业绩扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/03/25105535061542.shtml",
    "datetime": "2022-03-25 10:55:23",
    "code": "300233"
  },
  {
    "title": "金城医药2021年净利1.08亿同比扭亏为盈 董事长赵叶青薪酬173.92万",
    "href": "http://stock.jrj.com.cn/2022/03/24231234959469.shtml",
    "datetime": "2022-03-24 23:12:56",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：拟向银行等金融机构申请预计不超18.5亿元综合授信额度",
    "href": "http://stock.jrj.com.cn/2022/03/24212434944679.shtml",
    "datetime": "2022-03-24 21:24:47",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：拟开展不超6亿元的远期外汇交易业务",
    "href": "http://stock.jrj.com.cn/2022/03/24194734929725.shtml",
    "datetime": "2022-03-24 19:47:55",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：拟使用不超3.5亿元闲置自有资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2022/03/24194634929726.shtml",
    "datetime": "2022-03-24 19:46:28",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：减持期届满 副总裁杨修亮累计减持5000股",
    "href": "http://stock.jrj.com.cn/2022/03/24194434929732.shtml",
    "datetime": "2022-03-24 19:44:58",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)2021年度业绩扭亏为盈至1.08亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2022/03/24183234917953.shtml",
    "datetime": "2022-03-24 18:32:09",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)下修业绩预告：2021年度预盈0.9亿元-1.15亿元",
    "href": "http://stock.jrj.com.cn/2022/03/16185334835383.shtml",
    "datetime": "2022-03-16 18:53:14",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司金城素智通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2022/03/01172134508619.shtml",
    "datetime": "2022-03-01 17:21:47",
    "code": "300233"
  },
  {
    "title": "金城医药：拟于3月14日召开2022年第二次临时股东大会",
    "href": "http://stock.jrj.com.cn/2022/02/22103234433652.shtml",
    "datetime": "2022-02-22 10:32:31",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：拟推353.64万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/02/21174134423078.shtml",
    "datetime": "2022-02-21 17:41:59",
    "code": "300233"
  },
  {
    "title": "金城医药：泊沙康唑原料药通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/02/14200634346115.shtml",
    "datetime": "2022-02-14 20:06:40",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：泊沙康唑原料药通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/02/14174434345314.shtml",
    "datetime": "2022-02-14 17:44:58",
    "code": "300233"
  },
  {
    "title": "金城医药：拟为子公司金城柯瑞提供不超2000万元担保",
    "href": "http://stock.jrj.com.cn/2022/02/11003634321477.shtml",
    "datetime": "2022-02-11 00:36:09",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药涨近7% 丁二磺酸腺苷蛋氨酸通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/02/10094934317171.shtml",
    "datetime": "2022-02-10 09:49:52",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司丁二磺酸腺苷蛋氨酸非无菌原料药注册申请通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/02/09195034314531.shtml",
    "datetime": "2022-02-09 19:50:45",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药涨6% 2021年度预盈1.4亿元-1.7亿元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/01/12095134148814.shtml",
    "datetime": "2022-01-12 09:51:42",
    "code": "300233"
  },
  {
    "title": "金城医药2021年预计净利1.4亿-1.7亿同比扭亏为盈 上年业绩受计提商誉减值准备影响导致亏损",
    "href": "http://stock.jrj.com.cn/2022/01/11202334147463.shtml",
    "datetime": "2022-01-11 20:23:34",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：2021年度预盈1.4亿元-1.7亿元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2022/01/11174834146778.shtml",
    "datetime": "2022-01-11 17:48:09",
    "code": "300233"
  },
  {
    "title": "【龙虎榜】金城医药12月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/28180434077140.shtml",
    "datetime": "2021-12-28 18:04:30",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：副总裁杨修亮减持期过半 尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/12/23162134052892.shtml",
    "datetime": "2021-12-23 16:21:28",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：减持数过半 北京锦圣已减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/12/16174534024924.shtml",
    "datetime": "2021-12-16 17:45:19",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金已减持3.40%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/06212033975540.shtml",
    "datetime": "2021-12-06 21:20:06",
    "code": "300233"
  },
  {
    "title": "A股异动 | 电子烟概念股低开 金城医药跌超17%",
    "href": "http://stock.jrj.com.cn/2021/12/01093233948179.shtml",
    "datetime": "2021-12-01 09:32:38",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/11/29164433938263.shtml",
    "datetime": "2021-11-29 16:44:05",
    "code": "300233"
  },
  {
    "title": "金城医药：公司获得的是烟碱(尼古丁)的安全生产许可证 可以向下游企业销售",
    "href": "http://stock.jrj.com.cn/2021/11/29145033937784.shtml",
    "datetime": "2021-11-29 14:50:26",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东金城实业解押304.66万股",
    "href": "http://stock.jrj.com.cn/2021/11/24202733915559.shtml",
    "datetime": "2021-11-24 20:27:14",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金已减持1.16%的股份",
    "href": "http://stock.jrj.com.cn/2021/11/23204133911099.shtml",
    "datetime": "2021-11-23 20:41:40",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金城医化取得安全生产许可证",
    "href": "http://stock.jrj.com.cn/2021/11/10163633831920.shtml",
    "datetime": "2021-11-10 16:36:41",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司注射用头孢噻肟钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/10/26172733755416.shtml",
    "datetime": "2021-10-26 17:27:13",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：第三季度净利降29.08%至2733.41万元",
    "href": "http://stock.jrj.com.cn/2021/10/26172433755400.shtml",
    "datetime": "2021-10-26 17:24:16",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东解除质押273万股",
    "href": "http://stock.jrj.com.cn/2021/10/22210833735525.shtml",
    "datetime": "2021-10-22 21:08:45",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金8月25日以来共减持1.04%股份",
    "href": "http://stock.jrj.com.cn/2021/09/23171033505127.shtml",
    "datetime": "2021-09-23 17:10:32",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药(300233.SZ)跌逾5% 股东拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2021/09/15094333437908.shtml",
    "datetime": "2021-09-15 09:43:27",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：持股7.31%的锦圣基金拟减持不超2%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/14204233435375.shtml",
    "datetime": "2021-09-14 20:42:40",
    "code": "300233"
  },
  {
    "title": "金城医药股东锦圣基金减持774.21万股 套现2.14亿 上半年公司净利9300.54万",
    "href": "http://stock.jrj.com.cn/2021/09/06223633394731.shtml",
    "datetime": "2021-09-06 22:36:41",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金已通过集中竞价累计减持2.017%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/06203133394319.shtml",
    "datetime": "2021-09-06 20:31:19",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司获得注射用头孢唑林钠一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2021/09/02155033374426.shtml",
    "datetime": "2021-09-02 15:50:17",
    "code": "300233"
  },
  {
    "title": "金城医药副总裁杨修亮拟减持不超3.38万股公司股份 上半年公司净利9300.54万",
    "href": "http://stock.jrj.com.cn/2021/08/30220433355601.shtml",
    "datetime": "2021-08-30 22:04:37",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：副总裁杨修亮拟减持不超3.375万股",
    "href": "http://stock.jrj.com.cn/2021/08/30200433354784.shtml",
    "datetime": "2021-08-30 20:04:43",
    "code": "300233"
  },
  {
    "title": "金城医药：上半年净利润9300万元 同比下降45%",
    "href": "http://stock.jrj.com.cn/2021/08/27071533330402.shtml",
    "datetime": "2021-08-27 07:15:00",
    "code": "300233"
  },
  {
    "title": "金城医药2021年半年度净利9300.54万元 同比净利减少45.01%",
    "href": "http://stock.jrj.com.cn/2021/08/26164533324719.shtml",
    "datetime": "2021-08-26 16:45:31",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金已累计减持396.92万股",
    "href": "http://stock.jrj.com.cn/2021/08/24221333312212.shtml",
    "datetime": "2021-08-24 22:13:29",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：锦圣基金已累计减持1500.1486万股",
    "href": "http://stock.jrj.com.cn/2021/08/17221233269334.shtml",
    "datetime": "2021-08-17 22:12:37",
    "code": "300233"
  },
  {
    "title": "金城医药获批筹建山东省技术创新中心",
    "href": "http://stock.jrj.com.cn/2021/08/13140333248189.shtml",
    "datetime": "2021-08-13 14:03:33",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东解质467万股",
    "href": "http://stock.jrj.com.cn/2021/07/23213233142072.shtml",
    "datetime": "2021-07-23 21:32:54",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药(300233.SZ)月内涨幅近50% 200吨/年烟碱产业化项目即将完工",
    "href": "http://stock.jrj.com.cn/2021/07/16102733106146.shtml",
    "datetime": "2021-07-16 10:27:51",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：“200 吨/年烟碱产业化项目”计划于2021年9月底完工",
    "href": "http://stock.jrj.com.cn/2021/07/15213833103727.shtml",
    "datetime": "2021-07-15 21:38:54",
    "code": "300233"
  },
  {
    "title": "【龙虎榜】金城医药7月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/15180633102686.shtml",
    "datetime": "2021-07-15 18:06:11",
    "code": "300233"
  },
  {
    "title": "【龙虎榜】金城医药7月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/14180533095688.shtml",
    "datetime": "2021-07-14 18:05:50",
    "code": "300233"
  },
  {
    "title": "金城医药：公司尼古丁产品中不存在N-亚硝胺类物质",
    "href": "http://stock.jrj.com.cn/2021/06/24134032989090.shtml",
    "datetime": "2021-06-24 13:40:26",
    "code": "300233"
  },
  {
    "title": "金城医药：公司具备相应的尼古丁产品加工技术能力",
    "href": "http://stock.jrj.com.cn/2021/06/24133932989080.shtml",
    "datetime": "2021-06-24 13:39:08",
    "code": "300233"
  },
  {
    "title": "金城医药：头孢他啶侧链酸活性酯扩产项目设计建设产能1000吨/年的头孢他啶侧链酸活性酯",
    "href": "http://stock.jrj.com.cn/2021/06/24131532988970.shtml",
    "datetime": "2021-06-24 13:15:31",
    "code": "300233"
  },
  {
    "title": "金城医药：公司注射用头孢唑林钠、注射用头孢他啶各一个品规为第五批医药集采拟中选产品",
    "href": "http://stock.jrj.com.cn/2021/06/24111932988486.shtml",
    "datetime": "2021-06-24 11:19:19",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：两款药品拟中选第五轮集采",
    "href": "http://stock.jrj.com.cn/2021/06/24085832987305.shtml",
    "datetime": "2021-06-24 08:58:08",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：注射用头孢唑林钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/23213632985273.shtml",
    "datetime": "2021-06-23 21:36:03",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：金城金素成为卡贝缩宫素注射液上市许可持有人",
    "href": "http://stock.jrj.com.cn/2021/06/17164432948029.shtml",
    "datetime": "2021-06-17 16:44:24",
    "code": "300233"
  },
  {
    "title": "金城医药：公司烟碱项目正处于建设过程中",
    "href": "http://stock.jrj.com.cn/2021/06/17095332945846.shtml",
    "datetime": "2021-06-17 09:53:32",
    "code": "300233"
  },
  {
    "title": "金城医药：尼古丁样品已经有试用",
    "href": "http://stock.jrj.com.cn/2021/06/17095332945844.shtml",
    "datetime": "2021-06-17 09:53:29",
    "code": "300233"
  },
  {
    "title": "金城医药：《打击非法医疗美容服务专项整治工作方案》不会对金城肽美的正常业务产生影响",
    "href": "http://stock.jrj.com.cn/2021/06/17091032945522.shtml",
    "datetime": "2021-06-17 09:10:30",
    "code": "300233"
  },
  {
    "title": "A股异动 | 金城医药(300233.SZ)跌逾4% 北京锦圣已累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/06/10144732904991.shtml",
    "datetime": "2021-06-10 14:47:27",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：北京锦圣减持期过半 累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/06/09191732900968.shtml",
    "datetime": "2021-06-09 19:17:07",
    "code": "300233"
  },
  {
    "title": "金城医药：公司烟碱项目目前处于建设期 预计10月份投产",
    "href": "http://stock.jrj.com.cn/2021/06/02200532865175.shtml",
    "datetime": "2021-06-02 20:05:29",
    "code": "300233"
  },
  {
    "title": "金城医药：在建的VD3项目立项是依托于生物产业园建设而进行的 目前未启动该产品建设",
    "href": "http://stock.jrj.com.cn/2021/06/02200432865177.shtml",
    "datetime": "2021-06-02 20:04:50",
    "code": "300233"
  },
  {
    "title": "金城医药：公司会持续关注CDMO行业的发展情况",
    "href": "http://stock.jrj.com.cn/2021/06/02200232865176.shtml",
    "datetime": "2021-06-02 20:02:13",
    "code": "300233"
  },
  {
    "title": "金城医药：制备大麻二酚中间体的方法专利是公司对大麻相关的技术研究和储备",
    "href": "http://stock.jrj.com.cn/2021/06/02200032865153.shtml",
    "datetime": "2021-06-02 20:00:14",
    "code": "300233"
  },
  {
    "title": "金城医药：公司谷胱甘肽原料药可以用于药品和保健类产品的生产",
    "href": "http://stock.jrj.com.cn/2021/06/02195732865152.shtml",
    "datetime": "2021-06-02 19:57:57",
    "code": "300233"
  },
  {
    "title": "金城医药：公司烟碱产品可以应用于医药、化工、农药和电子烟等多个领域",
    "href": "http://stock.jrj.com.cn/2021/06/02195532865121.shtml",
    "datetime": "2021-06-02 19:55:42",
    "code": "300233"
  },
  {
    "title": "金城医药：自2021年5月10日起 已开展第五批集采的申报工作",
    "href": "http://stock.jrj.com.cn/2021/06/02195432865120.shtml",
    "datetime": "2021-06-02 19:54:19",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)2020年度权益分派10派2.018424元 股权登记日为6月3日",
    "href": "http://stock.jrj.com.cn/2021/05/30132732840888.shtml",
    "datetime": "2021-05-30 13:27:05",
    "code": "300233"
  },
  {
    "title": "金城医药：为子公司提供担保",
    "href": "http://stock.jrj.com.cn/2021/05/25161032816938.shtml",
    "datetime": "2021-05-25 16:10:52",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：持股5%以上的锦圣基金已减持385.46万股",
    "href": "http://stock.jrj.com.cn/2021/05/24172232811214.shtml",
    "datetime": "2021-05-24 17:22:49",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)回购实施完成 耗资7999.81万元回购353.64万股",
    "href": "http://stock.jrj.com.cn/2021/05/20155132787332.shtml",
    "datetime": "2021-05-20 15:51:27",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：4月30日首次回购34.14万股",
    "href": "http://stock.jrj.com.cn/2021/04/30164432487612.shtml",
    "datetime": "2021-04-30 16:44:22",
    "code": "300233"
  },
  {
    "title": "金城医药：公司目前在售产品中有谷胱甘肽原料可以用于化妆品",
    "href": "http://stock.jrj.com.cn/2021/04/30131932486374.shtml",
    "datetime": "2021-04-30 13:19:55",
    "code": "300233"
  },
  {
    "title": "金城医药：公司与恒信共同申报尼古丁技术工艺专利有利于公司产品未来市场的拓展",
    "href": "http://stock.jrj.com.cn/2021/04/30112332485787.shtml",
    "datetime": "2021-04-30 11:23:17",
    "code": "300233"
  },
  {
    "title": "金城医药：客户采购尼古丁产品备案即可",
    "href": "http://stock.jrj.com.cn/2021/04/30111432485689.shtml",
    "datetime": "2021-04-30 11:14:43",
    "code": "300233"
  },
  {
    "title": "金城医药：目前公司暂未无流感相关流域产品",
    "href": "http://stock.jrj.com.cn/2021/04/30103732485367.shtml",
    "datetime": "2021-04-30 10:37:27",
    "code": "300233"
  },
  {
    "title": "金城医药：合成尼古丁相比较提取法获取的尼古丁可以去除更多有害物质",
    "href": "http://stock.jrj.com.cn/2021/04/30085632484550.shtml",
    "datetime": "2021-04-30 08:56:43",
    "code": "300233"
  },
  {
    "title": "金城医药：公司（无菌原料药）丁二磺酸腺苷蛋氨酸 该产品尚未进行销售",
    "href": "http://stock.jrj.com.cn/2021/04/30083832484466.shtml",
    "datetime": "2021-04-30 08:38:51",
    "code": "300233"
  },
  {
    "title": "金城医药：公司注射用头孢他啶已通过仿制药质量与疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/30083032484438.shtml",
    "datetime": "2021-04-30 08:30:46",
    "code": "300233"
  },
  {
    "title": "金城医药：s-尼古丁的专利撤回主要出于技术保护方面的考虑",
    "href": "http://stock.jrj.com.cn/2021/04/16131032385820.shtml",
    "datetime": "2021-04-16 13:10:26",
    "code": "300233"
  },
  {
    "title": "金城医药：目前公司烟碱项目正在按计划推进建设",
    "href": "http://stock.jrj.com.cn/2021/04/16102132384832.shtml",
    "datetime": "2021-04-16 10:21:11",
    "code": "300233"
  },
  {
    "title": "金城医药：公司在意大利的合资公司有研发一款防蓝光的滴眼液产品",
    "href": "http://stock.jrj.com.cn/2021/04/16101432384734.shtml",
    "datetime": "2021-04-16 10:14:27",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/04/02190932271805.shtml",
    "datetime": "2021-04-02 19:09:37",
    "code": "300233"
  },
  {
    "title": "金城医药：公司尼古丁产品可用于医药、化工、农药以及电子烟等多个领域",
    "href": "http://stock.jrj.com.cn/2021/03/24071832206067.shtml",
    "datetime": "2021-03-24 07:18:58",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：睿亿投资减持计划提前实施完毕 持股降至5%以下",
    "href": "http://stock.jrj.com.cn/2021/03/19175132165043.shtml",
    "datetime": "2021-03-19 17:51:47",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东解除质押800万股",
    "href": "http://stock.jrj.com.cn/2021/03/17165432151596.shtml",
    "datetime": "2021-03-17 16:54:50",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东质押777万股及解除质押125万股",
    "href": "http://stock.jrj.com.cn/2021/03/15155132136648.shtml",
    "datetime": "2021-03-15 15:51:56",
    "code": "300233"
  },
  {
    "title": "金城医药：1000吨/年呋喃铵盐项目将在二期建设",
    "href": "http://stock.jrj.com.cn/2021/03/10103432102423.shtml",
    "datetime": "2021-03-10 10:34:09",
    "code": "300233"
  },
  {
    "title": "金城医药商誉“爆雷”预亏近5亿 200吨的尼古丁项目何时“落地”",
    "href": "http://stock.jrj.com.cn/2021/03/08074132089020.shtml",
    "datetime": "2021-03-08 07:41:06",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：披露VGX-3100项目的首个III期临床试验(REVEAL1阶段)进展",
    "href": "http://stock.jrj.com.cn/2021/03/05160832078444.shtml",
    "datetime": "2021-03-05 16:08:54",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：注射用头孢曲松钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/02165432057954.shtml",
    "datetime": "2021-03-02 16:54:11",
    "code": "300233"
  },
  {
    "title": "金城医药：公司2350t/a 医药系列中间体项目（一期）建设项目安全条件审查和环境影响报告书均已获批准",
    "href": "http://stock.jrj.com.cn/2021/02/26183232034384.shtml",
    "datetime": "2021-02-26 18:32:00",
    "code": "300233"
  },
  {
    "title": "【龙虎榜】金城医药2月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/23180832013452.shtml",
    "datetime": "2021-02-23 18:08:33",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：持股5%以上股东锦圣基金拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2021/02/10160831883613.shtml",
    "datetime": "2021-02-10 16:08:51",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：董事长赵叶青累计增持250.75万股 增持计划实施完毕",
    "href": "http://stock.jrj.com.cn/2021/02/08215231872716.shtml",
    "datetime": "2021-02-08 21:52:11",
    "code": "300233"
  },
  {
    "title": "金城医药董事长赵叶青增持250.75万股 耗资4903.55万",
    "href": "http://stock.jrj.com.cn/2021/02/08204931872241.shtml",
    "datetime": "2021-02-08 20:49:39",
    "code": "300233"
  },
  {
    "title": "金城医药：目前淄博市生态环境局已于2021年1月26日-2月1日进行了烟碱产品拟审批项目公示",
    "href": "http://stock.jrj.com.cn/2021/02/07070531859758.shtml",
    "datetime": "2021-02-07 07:05:27",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：股东锦圣基金自2020年7月18日以来累计减持6.04%股份",
    "href": "http://stock.jrj.com.cn/2021/02/04205031850844.shtml",
    "datetime": "2021-02-04 20:50:00",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：股东锦圣基金累计减持517万股",
    "href": "http://stock.jrj.com.cn/2021/02/04181931849927.shtml",
    "datetime": "2021-02-04 18:19:44",
    "code": "300233"
  },
  {
    "title": "金城医药：目前项目建设手续正在办理过程中",
    "href": "http://stock.jrj.com.cn/2021/01/22114631743711.shtml",
    "datetime": "2021-01-22 11:46:30",
    "code": "300233"
  },
  {
    "title": "金城医药集团安斯夫ANCEF0.5g注射用 头孢唑林钠首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/22071631741932.shtml",
    "datetime": "2021-01-22 07:16:00",
    "code": "300233"
  },
  {
    "title": "销量下滑研发费用增加，金城医药2020年归母净利润预亏不低于4亿",
    "href": "http://stock.jrj.com.cn/2021/01/21085031734331.shtml",
    "datetime": "2021-01-21 08:50:27",
    "code": "300233"
  },
  {
    "title": "金城医药业绩预告：计提7.4亿元商誉减值 2020年度净利润亏损4.5亿元-5亿元",
    "href": "http://stock.jrj.com.cn/2021/01/20172431729959.shtml",
    "datetime": "2021-01-20 17:24:40",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：注射用头孢唑林钠首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/19183531723180.shtml",
    "datetime": "2021-01-19 18:35:47",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：控股股东解除质押246万股",
    "href": "http://stock.jrj.com.cn/2021/01/15161331698709.shtml",
    "datetime": "2021-01-15 16:13:51",
    "code": "300233"
  },
  {
    "title": "金城医药业绩爆雷背后还有隐患",
    "href": "http://stock.jrj.com.cn/2021/01/14001131686903.shtml",
    "datetime": "2021-01-14 00:11:44",
    "code": "300233"
  },
  {
    "title": "金城医药股东崔希礼减持2万股 套现约80万元",
    "href": "http://stock.jrj.com.cn/2021/01/13215131686520.shtml",
    "datetime": "2021-01-13 21:51:40",
    "code": "300233"
  },
  {
    "title": "又要“准备”7.4亿，3年累计商誉减值将达11.5亿 金城医药股价这几天不跌反涨",
    "href": "http://stock.jrj.com.cn/2021/01/13213031686377.shtml",
    "datetime": "2021-01-13 21:30:17",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：3名高管合计减持6.28万股 减持计划实施完毕",
    "href": "http://stock.jrj.com.cn/2021/01/13171631684926.shtml",
    "datetime": "2021-01-13 17:16:03",
    "code": "300233"
  },
  {
    "title": "金城医药18.8亿收购爆雷全年预亏5亿 连续三年计提减值11.4亿商誉归零",
    "href": "http://stock.jrj.com.cn/2021/01/13080831681770.shtml",
    "datetime": "2021-01-13 08:08:31",
    "code": "300233"
  },
  {
    "title": "“踩雷”金城泰尔 金城医药跌进亏损泥潭",
    "href": "http://stock.jrj.com.cn/2021/01/13012631679063.shtml",
    "datetime": "2021-01-13 01:26:53",
    "code": "300233"
  },
  {
    "title": "金城医药两收购商誉减值准备7亿 其一为中信证券项目",
    "href": "http://stock.jrj.com.cn/2021/01/12133931675944.shtml",
    "datetime": "2021-01-12 13:39:00",
    "code": "300233"
  },
  {
    "title": "由盈转亏！金城医药因商誉减值影响业绩预亏4.5亿元至-5亿元",
    "href": "http://stock.jrj.com.cn/2021/01/12110131675212.shtml",
    "datetime": "2021-01-12 11:01:38",
    "code": "300233"
  },
  {
    "title": "金城医药：计提商誉减值准备 2020年预亏4.5亿元-5亿元",
    "href": "http://stock.jrj.com.cn/2021/01/11203431672106.shtml",
    "datetime": "2021-01-11 20:34:52",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：2020年度预亏4.5亿元-5亿元",
    "href": "http://stock.jrj.com.cn/2021/01/11202231672048.shtml",
    "datetime": "2021-01-11 20:22:36",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：回购期届满 累计回购3354.2万元股份",
    "href": "http://stock.jrj.com.cn/2021/01/08163531655581.shtml",
    "datetime": "2021-01-08 16:35:41",
    "code": "300233"
  },
  {
    "title": "金城医药张学波辞去总经理职务仍在公司担任副董事长 李家全担任总经理",
    "href": "http://stock.jrj.com.cn/2021/01/04200931629008.shtml",
    "datetime": "2021-01-04 20:09:42",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：子公司获得头孢羟氨苄胶囊一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2020/12/25172131570941.shtml",
    "datetime": "2020-12-25 17:21:28",
    "code": "300233"
  },
  {
    "title": "金城医药荣获2020年度山东省“品质鲁药”建设示范企业荣誉",
    "href": "http://stock.jrj.com.cn/2020/12/25071131566699.shtml",
    "datetime": "2020-12-25 07:11:00",
    "code": "300233"
  },
  {
    "title": "金城医药跌10.87% 光大永明资管为第六大流通股东",
    "href": "http://stock.jrj.com.cn/2020/12/24182031562744.shtml",
    "datetime": "2020-12-24 18:20:00",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：持股5%以上股东锦圣基金累计减持1.23%股份",
    "href": "http://stock.jrj.com.cn/2020/12/18170731519284.shtml",
    "datetime": "2020-12-18 17:07:10",
    "code": "300233"
  },
  {
    "title": "金城医药：公司谷胱甘肽设计产能为500吨/年",
    "href": "http://stock.jrj.com.cn/2020/12/17155231509611.shtml",
    "datetime": "2020-12-17 15:52:38",
    "code": "300233"
  },
  {
    "title": "金城医药：医药系列中间体项目分三期建设 根据环评报告需要做两次环评",
    "href": "http://stock.jrj.com.cn/2020/12/04164131408627.shtml",
    "datetime": "2020-12-04 16:41:53",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)截至11月底累计回购107.73万股",
    "href": "http://stock.jrj.com.cn/2020/12/01171531385661.shtml",
    "datetime": "2020-12-01 17:15:26",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：媒体报道烟碱项目每年将创收60亿与现实不符",
    "href": "http://stock.jrj.com.cn/2020/11/26204931355341.shtml",
    "datetime": "2020-11-26 20:49:26",
    "code": "300233"
  },
  {
    "title": "金城医药：2350t/a医药系列中间体项目具体在公司全资子公司山东金城医药化工有限公司实施",
    "href": "http://stock.jrj.com.cn/2020/11/10105131249446.shtml",
    "datetime": "2020-11-10 10:51:59",
    "code": "300233"
  },
  {
    "title": "金城医药：该200吨烟碱项目为公司“2350t/a医药系列中间体项目”中的一项",
    "href": "http://stock.jrj.com.cn/2020/11/06131531229984.shtml",
    "datetime": "2020-11-06 13:15:47",
    "code": "300233"
  },
  {
    "title": "金城医药：公司产品不涉及医美领域",
    "href": "http://stock.jrj.com.cn/2020/11/06103631229049.shtml",
    "datetime": "2020-11-06 10:36:38",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)：截至10月末 累计耗资2335.78万元回购76.88万股",
    "href": "http://stock.jrj.com.cn/2020/11/03161431208794.shtml",
    "datetime": "2020-11-03 16:14:10",
    "code": "300233"
  },
  {
    "title": "金城医药2020年前三季度净利2.08亿下滑52.25% 销售费用增长",
    "href": "http://stock.jrj.com.cn/2020/10/27211331144518.shtml",
    "datetime": "2020-10-27 21:13:21",
    "code": "300233"
  },
  {
    "title": "金城医药：目前烟碱项目土建、安评、环评等相关工作正在推进中",
    "href": "http://stock.jrj.com.cn/2020/10/23160231116614.shtml",
    "datetime": "2020-10-23 16:02:12",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司拟斥1亿元设立金城医药研究院",
    "href": "http://stock.jrj.com.cn/2020/09/29223730861957.shtml",
    "datetime": "2020-09-29 22:37:09",
    "code": "300233"
  },
  {
    "title": "金城医药全资子公司拟出资1亿元对外投资设立金城医药研究院",
    "href": "http://stock.jrj.com.cn/2020/09/29213530861713.shtml",
    "datetime": "2020-09-29 21:35:15",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)拟开展远期外汇交易业务",
    "href": "http://stock.jrj.com.cn/2020/09/29191130861021.shtml",
    "datetime": "2020-09-29 19:11:53",
    "code": "300233"
  },
  {
    "title": "金城医药(300233.SZ)子公司拟斥1亿元设立金城医药研究院",
    "href": "http://stock.jrj.com.cn/2020/09/29191130861024.shtml",
    "datetime": "2020-09-29 19:11:08",
    "code": "300233"
  },
  {
    "title": "金城医药2020年上半年净利1.69亿下滑48% 用药品种及数量下降",
    "href": "http://stock.jrj.com.cn/2020/08/20230030552220.shtml",
    "datetime": "2020-08-20 23:00:29",
    "code": "300233"
  },
  {
    "title": "【龙虎榜】金城医药7月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/20180630294236.shtml",
    "datetime": "2020-07-20 18:06:02",
    "code": "300233"
  },
  {
    "title": "金城医药股东协议转让减持2000万股 占总股本5.11%",
    "href": "http://stock.jrj.com.cn/2020/07/19120330281558.shtml",
    "datetime": "2020-07-19 12:03:00",
    "code": "300233"
  },
  {
    "title": "金城医药将花不超4500万元回购公司股份 用于减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2020/07/09194030194072.shtml",
    "datetime": "2020-07-09 19:40:58",
    "code": "300233"
  },
  {
    "title": "金城医药：股东锦圣基金拟减持不超2%",
    "href": "http://stock.jrj.com.cn/2020/07/07190630169443.shtml",
    "datetime": "2020-07-07 19:06:45",
    "code": "300233"
  },
  {
    "title": "快讯：金城医药急速拉升6.03% 主力资金净流入1829.13万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/07100730163621.shtml",
    "datetime": "2020-07-07 10:07:33",
    "code": "300233"
  },
  {
    "title": "快讯：金城医药急速拉升5.54% 主力资金净流入1370.16万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/06094730150296.shtml",
    "datetime": "2020-07-06 09:47:22",
    "code": "300233"
  },
  {
    "title": "二股东27.18亿元股权上架淘宝拍卖 金城医药深陷仿制药收购大雷",
    "href": "http://stock.jrj.com.cn/2020/07/01084030107027.shtml",
    "datetime": "2020-07-01 08:40:54",
    "code": "300233"
  },
  {
    "title": "快讯：金城医药急速拉升7.44% 主力资金净流入546.50万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/24094030007083.shtml",
    "datetime": "2020-06-24 09:40:45",
    "code": "300233"
  },
  {
    "title": "罕见！第一大股东欲通过网络拍卖“让位” 起价27亿元 引千余人次围观",
    "href": "http://stock.jrj.com.cn/2020/06/22065829984956.shtml",
    "datetime": "2020-06-22 06:58:15",
    "code": "300233"
  },
  {
    "title": "【公告解读】金城医药：拟斥资3000万元-4500万元回购股份",
    "href": "http://stock.jrj.com.cn/2020/06/19215229969370.shtml",
    "datetime": "2020-06-19 21:52:48",
    "code": "300233"
  },
  {
    "title": "金城医药：拟6个月内回购0.22%-0.33%的股份",
    "href": "http://stock.jrj.com.cn/2020/06/19212329969200.shtml",
    "datetime": "2020-06-19 21:23:43",
    "code": "300233"
  },
  {
    "title": "金城医药：三大板块齐头并进 欧洲透明质酸明年开始销售",
    "href": "http://stock.jrj.com.cn/2020/05/21172429731959.shtml",
    "datetime": "2020-05-21 17:24:00",
    "code": "300233"
  },
  {
    "title": "金城医药子公司多个药品获得再注册批件",
    "href": "http://stock.jrj.com.cn/2020/05/19220929714560.shtml",
    "datetime": "2020-05-19 22:09:29",
    "code": "300233"
  },
  {
    "title": "金城医药2020年第一季度净利1.01亿元增长3.02% 汇兑收益增加所致",
    "href": "http://stock.jrj.com.cn/2020/04/27235129398914.shtml",
    "datetime": "2020-04-27 23:51:37",
    "code": "300233"
  },
  {
    "title": "金城医药2020年一季度预计净利9807万元-1.27亿元 同比增长0%-30%",
    "href": "http://stock.jrj.com.cn/2020/04/09191129248480.shtml",
    "datetime": "2020-04-09 19:11:28",
    "code": "300233"
  },
  {
    "title": "金城医药：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/09171029246539.shtml",
    "datetime": "2020-04-09 17:10:00",
    "code": "300233"
  },
  {
    "title": "金城医药：关于重大资产重组限售股份解除限售的提示性公告",
    "href": "http://stock.jrj.com.cn/2020/03/23220029086059.shtml",
    "datetime": "2020-03-23 22:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药2019年净利润2.06亿元减少21.99% 子公司业绩下滑",
    "href": "http://stock.jrj.com.cn/2020/02/28192428916436.shtml",
    "datetime": "2020-02-28 19:24:14",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司定向驰援多家医疗机构抗感染防疫储备药品",
    "href": "http://stock.jrj.com.cn/2020/02/13143628823059.shtml",
    "datetime": "2020-02-13 14:36:00",
    "code": "300233"
  },
  {
    "title": "金城医药再度调拨103万元急需药物支援武汉 累计捐赠达553万元",
    "href": "http://stock.jrj.com.cn/2020/02/13112828822454.shtml",
    "datetime": "2020-02-13 11:28:00",
    "code": "300233"
  },
  {
    "title": "金城医药：累计捐赠现金、产品及各类防护物资约450万元",
    "href": "http://stock.jrj.com.cn/2020/02/12161828816105.shtml",
    "datetime": "2020-02-12 16:18:36",
    "code": "300233"
  },
  {
    "title": "金城医药：多个产品被列入广东省疫情防控参考药品需求目录",
    "href": "http://stock.jrj.com.cn/2020/02/07112128792061.shtml",
    "datetime": "2020-02-07 11:21:00",
    "code": "300233"
  },
  {
    "title": "金城医药：春节期间24小时加班加点 加紧补充库存",
    "href": "http://stock.jrj.com.cn/2020/02/07105728791934.shtml",
    "datetime": "2020-02-07 10:57:00",
    "code": "300233"
  },
  {
    "title": "金城医药：目前医药中间体板块生产经营正常",
    "href": "http://stock.jrj.com.cn/2020/02/07105428791933.shtml",
    "datetime": "2020-02-07 10:54:00",
    "code": "300233"
  },
  {
    "title": "金城医药：累计捐赠现金、产品及各类防护物资约450万元",
    "href": "http://stock.jrj.com.cn/2020/02/07104028791548.shtml",
    "datetime": "2020-02-07 10:40:00",
    "code": "300233"
  },
  {
    "title": "金城医药：匹多莫德分散片有利于新冠肺炎病人后期康复",
    "href": "http://stock.jrj.com.cn/2020/02/07103928791499.shtml",
    "datetime": "2020-02-07 10:39:36",
    "code": "300233"
  },
  {
    "title": "【e公司微访谈】金城医药：满负荷生产 全力保防控药品供应",
    "href": "http://stock.jrj.com.cn/2020/02/07103528791474.shtml",
    "datetime": "2020-02-07 10:35:00",
    "code": "300233"
  },
  {
    "title": "金城医药集团：捐赠450万元助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/04203228768575.shtml",
    "datetime": "2020-02-04 20:32:00",
    "code": "300233"
  },
  {
    "title": "金城医药：捐赠现金、防护物资等约450万元 抗击肺炎疫情",
    "href": "http://stock.jrj.com.cn/2020/02/04185728768255.shtml",
    "datetime": "2020-02-04 18:57:00",
    "code": "300233"
  },
  {
    "title": "金城医药向武汉同济医院捐赠匹多莫德",
    "href": "http://stock.jrj.com.cn/2020/01/28154728739385.shtml",
    "datetime": "2020-01-28 15:47:00",
    "code": "300233"
  },
  {
    "title": "金城医药：确保匹多莫德分散片足量供应 正启动药品捐赠",
    "href": "http://stock.jrj.com.cn/2020/01/28131628739191.shtml",
    "datetime": "2020-01-28 13:16:00",
    "code": "300233"
  },
  {
    "title": "金城医药2019年预计净利1.72亿元-2.51亿元 同比下降5%—35%",
    "href": "http://stock.jrj.com.cn/2020/01/20182128707004.shtml",
    "datetime": "2020-01-20 18:21:34",
    "code": "300233"
  },
  {
    "title": "金城医药：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/20170028706563.shtml",
    "datetime": "2020-01-20 17:00:01",
    "code": "300233"
  },
  {
    "title": "德展健康：终止收购金城医药25.05%股份",
    "href": "http://stock.jrj.com.cn/2020/01/05163728627739.shtml",
    "datetime": "2020-01-05 16:37:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城泰尔制药蒙脱石散通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/24000028578910.shtml",
    "datetime": "2019-12-24 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药子公司蒙脱石散获得一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/23164628573131.shtml",
    "datetime": "2019-12-23 16:46:53",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司蒙脱石散通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/23163528573071.shtml",
    "datetime": "2019-12-23 16:35:23",
    "code": "300233"
  },
  {
    "title": "金城医药：蒙脱石散通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/23160828572964.shtml",
    "datetime": "2019-12-23 16:08:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药集团召开“对标华为,助力高质量发展”动员会暨华为成功管理与实践培训会",
    "href": "http://stock.jrj.com.cn/2019/12/01000028481765.shtml",
    "datetime": "2019-12-01 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药3名股东合计减持1070万股 套现约2.26亿元",
    "href": "http://stock.jrj.com.cn/2019/11/23113928441135.shtml",
    "datetime": "2019-11-23 11:39:40",
    "code": "300233"
  },
  {
    "title": "金城医药：海通资管累计减持2.74%股份",
    "href": "http://stock.jrj.com.cn/2019/11/22183228439188.shtml",
    "datetime": "2019-11-22 18:32:56",
    "code": "300233"
  },
  {
    "title": "金城医药：海通资管减持2.74%股份 完成减持计划",
    "href": "http://stock.jrj.com.cn/2019/11/22174328438902.shtml",
    "datetime": "2019-11-22 17:43:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药与山东理工大学举办首届生物科技稷下论坛",
    "href": "http://stock.jrj.com.cn/2019/11/20000028426570.shtml",
    "datetime": "2019-11-20 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药2名股东拟减持股份 预计合计减持不超总股本0.34%",
    "href": "http://stock.jrj.com.cn/2019/11/15082128402905.shtml",
    "datetime": "2019-11-15 08:21:16",
    "code": "300233"
  },
  {
    "title": "金城医药：合计持股1.76%的两高管拟减持不超0.34%股份",
    "href": "http://stock.jrj.com.cn/2019/11/14163928399808.shtml",
    "datetime": "2019-11-14 16:39:37",
    "code": "300233"
  },
  {
    "title": "金城医药为全资子公司金城医化提供3900万元的连带责任保证担保",
    "href": "http://stock.jrj.com.cn/2019/11/12182328389080.shtml",
    "datetime": "2019-11-12 18:23:56",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药组织高管参加华为特训营并启动“对标华为,助力高质量发展”对标管理活动",
    "href": "http://stock.jrj.com.cn/2019/11/01000028344793.shtml",
    "datetime": "2019-11-01 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药第三季度盈利1.1亿 同比增长32%",
    "href": "http://stock.jrj.com.cn/2019/10/30153028325839.shtml",
    "datetime": "2019-10-30 15:30:04",
    "code": "300233"
  },
  {
    "title": "金城医药前三季度净利润同比增85.06%",
    "href": "http://stock.jrj.com.cn/2019/10/29225428320749.shtml",
    "datetime": "2019-10-29 22:54:55",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药集团与山东理工大学校企合作共建揭牌仪式举行",
    "href": "http://stock.jrj.com.cn/2019/10/23000028289150.shtml",
    "datetime": "2019-10-23 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药再获“最佳创业板上市公司”荣誉",
    "href": "http://stock.jrj.com.cn/2019/10/22000028289147.shtml",
    "datetime": "2019-10-22 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药上榜“品质鲁药”综合实力30强 赵叶青董事长当选“领军人物”",
    "href": "http://stock.jrj.com.cn/2019/10/22000028289149.shtml",
    "datetime": "2019-10-22 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城金素曲索芬荣登“2019年度中国最具创新力制剂品种”榜单",
    "href": "http://stock.jrj.com.cn/2019/10/13000028289148.shtml",
    "datetime": "2019-10-13 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/11222028235513.shtml",
    "datetime": "2019-10-11 22:20:00",
    "code": "300233"
  },
  {
    "title": "金城医药2019年前三季度净利约4亿元-4.71亿元 头孢粉针制剂销售稳步提升",
    "href": "http://stock.jrj.com.cn/2019/10/11184128234631.shtml",
    "datetime": "2019-10-11 18:41:45",
    "code": "300233"
  },
  {
    "title": "金城医药：前三季净利预增70%-100%",
    "href": "http://stock.jrj.com.cn/2019/10/11162728233490.shtml",
    "datetime": "2019-10-11 16:27:26",
    "code": "300233"
  },
  {
    "title": "金城医药：前三季度净利预增70%-100%",
    "href": "http://stock.jrj.com.cn/2019/10/11162628233488.shtml",
    "datetime": "2019-10-11 16:26:59",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司获国产保健食品注册证书",
    "href": "http://stock.jrj.com.cn/2019/10/10165928227379.shtml",
    "datetime": "2019-10-10 16:59:27",
    "code": "300233"
  },
  {
    "title": "金城医药：获得国产保健食品注册证书",
    "href": "http://stock.jrj.com.cn/2019/10/10165528227368.shtml",
    "datetime": "2019-10-10 16:55:49",
    "code": "300233"
  },
  {
    "title": "金城医药：获国产保健食品注册证书",
    "href": "http://stock.jrj.com.cn/2019/10/10164628227363.shtml",
    "datetime": "2019-10-10 16:46:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]北京市顺义区领导莅临北京金城泰尔调研指导工作",
    "href": "http://stock.jrj.com.cn/2019/10/02000028289146.shtml",
    "datetime": "2019-10-02 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：德展健康拟21-26亿元受让公司25.05%股权",
    "href": "http://stock.jrj.com.cn/2019/09/26154328184751.shtml",
    "datetime": "2019-09-26 15:43:32",
    "code": "300233"
  },
  {
    "title": "德展健康拟收购金城医药股权 挖掘新利润增长点",
    "href": "http://stock.jrj.com.cn/invest/2019/09/26090128183017.shtml",
    "datetime": "2019-09-26 09:01:00",
    "code": "300233"
  },
  {
    "title": "德展健康拟现金收购金城医药25.05%股份",
    "href": "http://stock.jrj.com.cn/2019/09/25224728180609.shtml",
    "datetime": "2019-09-25 22:47:10",
    "code": "300233"
  },
  {
    "title": "德展健康拟21-26亿元溢价收购金城医药25.05%股份",
    "href": "http://stock.jrj.com.cn/2019/09/25211728180373.shtml",
    "datetime": "2019-09-25 21:17:05",
    "code": "300233"
  },
  {
    "title": "德展健康：拟21亿-26亿元收购金城医药25.05%股份",
    "href": "http://stock.jrj.com.cn/2019/09/25204428180277.shtml",
    "datetime": "2019-09-25 20:44:37",
    "code": "300233"
  },
  {
    "title": "德展健康：就收购金城医药25.05%股份达成框架性条款",
    "href": "http://stock.jrj.com.cn/2019/09/25203728180271.shtml",
    "datetime": "2019-09-25 20:37:00",
    "code": "300233"
  },
  {
    "title": "金城医药为子公司金城生物提供不超过5000万连带责任保证担保",
    "href": "http://stock.jrj.com.cn/2019/09/23214828169451.shtml",
    "datetime": "2019-09-23 21:48:15",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药合理用药论坛暨产品上市会(山东·淄博站)成功举办",
    "href": "http://stock.jrj.com.cn/2019/09/22000028172564.shtml",
    "datetime": "2019-09-22 00:00:00",
    "code": "300233"
  },
  {
    "title": "【金城医药】大幅拉升5.11% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06144128100819.shtml",
    "datetime": "2019-09-06 14:41:22",
    "code": "300233"
  },
  {
    "title": "【金城医药】大幅拉升5.35% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06143628100799.shtml",
    "datetime": "2019-09-06 14:36:22",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药董事长赵叶青被授予“山东省优秀企业家”称号,被省委、省政府记一等功奖励",
    "href": "http://stock.jrj.com.cn/2019/09/01000028092245.shtml",
    "datetime": "2019-09-01 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药2019年上半年净利3.25亿 直接及间接持有金城金素84%的股权",
    "href": "http://stock.jrj.com.cn/2019/08/27172628041541.shtml",
    "datetime": "2019-08-27 17:26:35",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药跻身中国医药工业百强方阵",
    "href": "http://stock.jrj.com.cn/2019/08/27000028038691.shtml",
    "datetime": "2019-08-27 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：持股7.798%的股东拟减持不超2.74%",
    "href": "http://stock.jrj.com.cn/2019/08/23174728024052.shtml",
    "datetime": "2019-08-23 17:47:14",
    "code": "300233"
  },
  {
    "title": "金城医药：海通资管拟减持不超2.74%公司股份",
    "href": "http://stock.jrj.com.cn/2019/08/23173728023714.shtml",
    "datetime": "2019-08-23 17:37:53",
    "code": "300233"
  },
  {
    "title": "[金城医药]加快组织创新变革 推动企业高质量发展——金城医药集团召开合伙人项目发布暨组织创新推进大会",
    "href": "http://stock.jrj.com.cn/2019/08/23000028021096.shtml",
    "datetime": "2019-08-23 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]业界专家齐聚淄博 共论生物医药发展——淄博市生物智能制造发展高峰论坛成功举办",
    "href": "http://stock.jrj.com.cn/2019/08/23000028064506.shtml",
    "datetime": "2019-08-23 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：23个产品纳入医保目录 新增调入1个",
    "href": "http://stock.jrj.com.cn/2019/08/22163928017285.shtml",
    "datetime": "2019-08-22 16:39:29",
    "code": "300233"
  },
  {
    "title": "金城医药23个产品纳入医保目录 新增调入药品1个",
    "href": "http://stock.jrj.com.cn/2019/08/22162828017191.shtml",
    "datetime": "2019-08-22 16:28:15",
    "code": "300233"
  },
  {
    "title": "金城医药：23个产品纳入医保目录 新增调入药品1个",
    "href": "http://stock.jrj.com.cn/2019/08/22155128016940.shtml",
    "datetime": "2019-08-22 15:51:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]【众志成城 大爱无疆】金城医药集团捐款500万元支援淄川受灾群众重建家园",
    "href": "http://stock.jrj.com.cn/2019/08/22000028021095.shtml",
    "datetime": "2019-08-22 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]灾害无情人有情,金城医药爱心捐助受灾群众",
    "href": "http://stock.jrj.com.cn/2019/08/16000027985679.shtml",
    "datetime": "2019-08-16 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药:全力以赴抗击台风,确保企业安全生产",
    "href": "http://stock.jrj.com.cn/2019/08/12000027969164.shtml",
    "datetime": "2019-08-12 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]淄博市青年人才联络站(北京站)落户金城医药北京管理中心",
    "href": "http://stock.jrj.com.cn/2019/08/10000027976431.shtml",
    "datetime": "2019-08-10 00:00:00",
    "code": "300233"
  },
  {
    "title": "[互动]金城医药:子公司浙江磐谷药源有限公司目前业务未涉及工业大麻",
    "href": "http://stock.jrj.com.cn/2019/07/20160927865898.shtml",
    "datetime": "2019-07-20 16:09:34",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司浙江磐谷药源有限公司目前业务未涉及工业大麻",
    "href": "http://stock.jrj.com.cn/2019/07/20155827865885.shtml",
    "datetime": "2019-07-20 15:58:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]业界专家齐聚淄博 共论生物医药发展——淄博市生物智能制造发展高峰论坛成功举办",
    "href": "http://stock.jrj.com.cn/2019/07/18000027886179.shtml",
    "datetime": "2019-07-18 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：首次回购494万元股份",
    "href": "http://stock.jrj.com.cn/2019/07/03155927791559.shtml",
    "datetime": "2019-07-03 15:59:00",
    "code": "300233"
  },
  {
    "title": "金城医药2019年上半年净利3.5亿 比上年同期增长130%",
    "href": "http://stock.jrj.com.cn/2019/07/02075927784173.shtml",
    "datetime": "2019-07-02 07:59:00",
    "code": "300233"
  },
  {
    "title": "金城医药上半年净利预增100%-130%",
    "href": "http://stock.jrj.com.cn/2019/07/01180427779489.shtml",
    "datetime": "2019-07-01 18:04:15",
    "code": "300233"
  },
  {
    "title": "金城医药：上半年净利预增100%-130%",
    "href": "http://stock.jrj.com.cn/2019/07/01175127779395.shtml",
    "datetime": "2019-07-01 17:51:02",
    "code": "300233"
  },
  {
    "title": "金城医药将花不超1.2亿元回购公司股份 用于减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2019/06/20072627729088.shtml",
    "datetime": "2019-06-20 07:26:17",
    "code": "300233"
  },
  {
    "title": "金城医药：子公司获得注射用头孢唑林钠一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/06/11213027688147.shtml",
    "datetime": "2019-06-11 21:30:45",
    "code": "300233"
  },
  {
    "title": "金城医药子公司获得注射用头孢唑林钠一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/06/11185827687780.shtml",
    "datetime": "2019-06-11 18:58:16",
    "code": "300233"
  },
  {
    "title": "[金城医药]吴建民基金会法国创业青年代表团访问金城医药集团北京管理中心",
    "href": "http://stock.jrj.com.cn/2019/06/06000027672766.shtml",
    "datetime": "2019-06-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：拟斥资0.6亿至1.2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/06/03205427659238.shtml",
    "datetime": "2019-06-03 20:54:06",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城柯瑞荣登2019山东制造·硬科技TOP50品牌榜",
    "href": "http://stock.jrj.com.cn/2019/05/24000027619570.shtml",
    "datetime": "2019-05-24 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药入选深圳证券交易所四个指数样本股及深股通标的股名单",
    "href": "http://stock.jrj.com.cn/2019/05/16000027583732.shtml",
    "datetime": "2019-05-16 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药共建“一带一路”成果——金城医药联营企业意大利海宝露公司产品通过欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2019/04/27000027503604.shtml",
    "datetime": "2019-04-27 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药参股公司产品取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2019/04/10183127362265.shtml",
    "datetime": "2019-04-10 18:31:36",
    "code": "300233"
  },
  {
    "title": "金城医药：参股公司产品取得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2019/04/10160627361405.shtml",
    "datetime": "2019-04-10 16:06:00",
    "code": "300233"
  },
  {
    "title": "金城医药：2018年净利2.64亿元 拟10派2.5元",
    "href": "http://stock.jrj.com.cn/2019/04/10014127357258.shtml",
    "datetime": "2019-04-10 01:41:08",
    "code": "300233"
  },
  {
    "title": "金城医药去年净利2.64亿同比下滑8% 董事长赵叶青年薪150万元",
    "href": "http://stock.jrj.com.cn/2019/03/31112727276871.shtml",
    "datetime": "2019-03-31 11:27:42",
    "code": "300233"
  },
  {
    "title": "金城医药：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/28225027261412.shtml",
    "datetime": "2019-03-28 22:50:00",
    "code": "300233"
  },
  {
    "title": "金城医药收关注函：要求说明参股公司近三年财务数据摘要等",
    "href": "http://stock.jrj.com.cn/2019/03/21163927203362.shtml",
    "datetime": "2019-03-21 16:39:22",
    "code": "300233"
  },
  {
    "title": "金城医药：参股公司东方略符合登陆科创板条件 正进行相关辅导工作",
    "href": "http://stock.jrj.com.cn/2019/03/19162227191845.shtml",
    "datetime": "2019-03-19 16:22:00",
    "code": "300233"
  },
  {
    "title": "[互动]金城医药：公司投资的东方略公司符合登陆科创板的条件",
    "href": "http://stock.jrj.com.cn/2019/03/19152727191556.shtml",
    "datetime": "2019-03-19 15:27:44",
    "code": "300233"
  },
  {
    "title": "金城医药控股股东金城实业合计质押1322万股 去年营收同比增长8%",
    "href": "http://stock.jrj.com.cn/2019/03/14074127164320.shtml",
    "datetime": "2019-03-14 07:41:03",
    "code": "300233"
  },
  {
    "title": "[金城医药]“新时代、新理念、新担当”——金城医药集团召开管理人员大会",
    "href": "http://stock.jrj.com.cn/2019/03/14000027172680.shtml",
    "datetime": "2019-03-14 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]应势 变革 奋进——金城医药集团举行2018年度总结表彰大会、“唱响新时代”2019年迎新春文艺晚会",
    "href": "http://stock.jrj.com.cn/2019/03/14000027911679.shtml",
    "datetime": "2019-03-14 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药集团荣膺2018年山东省“厚道鲁商”品牌企业",
    "href": "http://stock.jrj.com.cn/2019/03/06000027129915.shtml",
    "datetime": "2019-03-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]资本赋能产业——金城医药、海通证券强强携手共谋发展",
    "href": "http://stock.jrj.com.cn/2019/03/06000027911685.shtml",
    "datetime": "2019-03-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]淄博市“双招双引”暨新旧动能转换重大工程推进大会召开,金城医药集团受表彰",
    "href": "http://stock.jrj.com.cn/2019/02/12000027035021.shtml",
    "datetime": "2019-02-12 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]应势 变革 奋进——金城医药集团举行2018年度总结表彰大会、“唱响新时代”2019年迎新春文艺晚会",
    "href": "http://stock.jrj.com.cn/2019/01/19000026936832.shtml",
    "datetime": "2019-01-19 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：股东金城实业向海通资管转让公司5.99%股份",
    "href": "http://stock.jrj.com.cn/2019/01/17174026919833.shtml",
    "datetime": "2019-01-17 17:40:20",
    "code": "300233"
  },
  {
    "title": "[金城医药]资本赋能产业——金城医药、海通证券强强携手共谋发展",
    "href": "http://stock.jrj.com.cn/2019/01/17000026935708.shtml",
    "datetime": "2019-01-17 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：控股股东向海通资管转让7.99%股份",
    "href": "http://stock.jrj.com.cn/2019/01/15212126908456.shtml",
    "datetime": "2019-01-15 21:21:06",
    "code": "300233"
  },
  {
    "title": "金城医药：拟逾2500万元购买房产",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/15075926905038.shtml",
    "datetime": "2019-01-15 07:59:59",
    "code": "300233"
  },
  {
    "title": "金城医药：拟2519.53万元购买关联方房产",
    "href": "http://stock.jrj.com.cn/2019/01/14203326902894.shtml",
    "datetime": "2019-01-14 20:33:55",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药获“中国百强企业奖”殊荣",
    "href": "http://stock.jrj.com.cn/2018/12/19000027655105.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]鲁渝有约 共创未来——金城医药与战略客户药友制药举行足球友谊赛",
    "href": "http://stock.jrj.com.cn/2018/12/19000027775622.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "300233"
  },
  {
    "title": "金城医药：公司产品不在“4+7”带量采购清单的采购范围中",
    "href": "http://stock.jrj.com.cn/2018/12/17110126753093.shtml",
    "datetime": "2018-12-17 11:01:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医化入选国家工信部绿色工厂名单",
    "href": "http://stock.jrj.com.cn/2018/12/10000027655106.shtml",
    "datetime": "2018-12-10 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药泰司汀牌头孢他啶(首创妇科感染专利适应症)获2018年度中国最具创新力制剂品种",
    "href": "http://stock.jrj.com.cn/2018/12/10000027775621.shtml",
    "datetime": "2018-12-10 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药获“中国百强企业奖”殊荣",
    "href": "http://stock.jrj.com.cn/2018/12/06000028064499.shtml",
    "datetime": "2018-12-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]开拓国际视野 精准对标学习——金城医药组团赴欧洲学习考察",
    "href": "http://stock.jrj.com.cn/2018/12/06000027525495.shtml",
    "datetime": "2018-12-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]金城医药集团品牌管理项目成果发布会举行",
    "href": "http://stock.jrj.com.cn/2018/12/06000027525497.shtml",
    "datetime": "2018-12-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]2018年度中国医药新锐榜揭晓,金城医药获最具市场潜力消化系统和儿科用药新锐奖!",
    "href": "http://stock.jrj.com.cn/2018/12/06000025463767.shtml",
    "datetime": "2018-12-06 00:00:00",
    "code": "300233"
  },
  {
    "title": "[金城医药]鲁渝有约 共创未来——金城医药与战略客户药友制药举行足球友谊赛",
    "href": "http://stock.jrj.com.cn/2018/12/06000025463768.shtml",
    "datetime": "2018-12-06 00:00:00",
    "code": "300233"
  }
]